http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3906311-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b561181c1d53b6a4785e165d7143e8a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1989-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d551950c4c884dc4cad254fc7d4c7cf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f87e599dd65e9cab7c88477f1d461d2
publicationDate 1990-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-3906311-A1
titleOfInvention TREATMENT SYSTEM FOR PREVENTING AFTER POSTAGE AFTER CATARACT OPERATION
abstract A treatment system for preventing secondary cataract formation after a cataract operation with a solution that inhibits growth of epithelial cells, a neutralising agent for this solution and an injection device which can be inserted in the crystalline capsule of a lens and with which the solution inhibiting growth of epithelial cells and the neutralising agent can be introduced into the crystalline capsule.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7875270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9283237-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013513622-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7985405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9789091-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011075430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006064281-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10413529-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2269576-A3
priorityDate 1989-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454394605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450006894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 39.